As they pop the champagne corks to celebrate New Year’s Eve, drug industry executives will likely be glad to put 2009 behind them. That’s because pharmaceutical companies who make top-selling drugs for heart disease, asthma, and many other conditions had a tough year in the midst of mounting market pressures and a global recession. A timely year-end analysis of the state of the pharmaceutical industry is scheduled for the current issue of Chemical & Engineering News, ACS’ weekly newsmagazine…

Read the rest here:
Drug Industry Embraces New Business Strategies After Tough Year

Related posts:

1. European Commission And Biopharmaceutical Industry Lay Out Steps To Improve Business Environment For Sector SMEsEBE, the European Biopharmaceutical Enterprises and the European Commission's Enterprise and Industry Directorate General today jointly presented a workshop on access to finance for small and medium-sized biopharmaceutical companies in...
2. Booming Business In Food Safety Fueled By Recalls, Food WorriesRecalls of ground beef, peanut butter, and other foods have done more than raise public awareness and concern about food safety. They also are quietly fueling a boom in the...
3. Association Of The British Pharmaceutical Industry Welcomes Patent BoxThe Association of the British Pharmaceutical Industry (ABPI) has welcomed the proposal for a 'patent box' outlined by Chancellor Alastair Darling in his Pre-Budget Report. The patent box is being...
4. Aptuit Publishes Study Which Demonstrates The Value Of Early Insights Into The Characterization Of Drug CompoundsAptuit, Inc. announced the publication of new research in the December issue of the European Journal of Pharmaceutical Sciences, the official journal of the European Federation for Pharmaceutical Sciences (EUFEPS),...
5. Student’s Award For Study Into Cancer Drug TargetA PhD student at The Institute of Cancer Research (ICR) has won an Europe-wide competition for her investigation into a promising anti-cancer drug target. Nicole Simonavicius was awarded first prize...
6. Climate Debate: What’s Warming Us Up? Human Activity Or Mother Nature?A major analysis of the climate debate concludes that the majority of scientists agree that global warming is primarily man-made, although a vocal minority of skeptics is holding onto the...
7. PlusNews Examines Push To Evaluate HIV Prevention StrategiesPlusNews examines the growing need to test how well HIV prevention strategies work - a topic addressed Monday at a Social Aspects of HIV/AIDS Research Alliance (SAHARA) conference in Johannesburg,...
8. Also In Global Health News: Illegal Drug Trade In E. Africa; Somalia Humanitarian Crisis; Alcohol, IV Drug Use In Russia; HIV/AIDS In China; MoreIllegal Drug Trade Turning East Africa Into Major Crime Center, U.N. Official Says In a speech to the U.N. Security Council Tuesday, Antonio Maria Costa, head of the U.N. Office...
9. Canadians Finding It Tough To Shake The Salt HabitCanadians know that too much salt isn't good for their diets, but half still continue to shake it on, according to a new study by University of Alberta researchers. ...
10. Alcohol Industry Should Prove No Harm In Funding Of SportsResearchers from Australia and the UK are calling for a new approach to the debate over whether alcohol industry sponsorship of sports increases drinking among sports participants. They want to...
11. Ohr Pharmaceutical Data Review Supports The Strong Potential Of Its Lead Drug OHR/AVR118 For CachexiaOhr Pharmaceutical Inc. (OTCBB: OHRP) is developing OHR/AVR118 for treatment of cachexia based on technology acquired earlier this year from Advanced Viral Research Corp. OHR/AVR118 has shown excellent therapeutic efficacy...
12. Review Your Medicare Health And Drug Plan Options For 2010 Carefully, Consumer Group AdvisesEveryone who is enrolled in a Medicare private health plan or stand-alone drug plan should review their coverage options for 2010, advises the Medicare Rights Center, a national consumer advocacy...
13. White House Deal With Drug Makers May Be Unraveling"Congressional Democrats' intensifying efforts to pay for their healthcare overhaul and provide more relief for consumers are threatening to unravel a White House deal with the pharmaceutical industry and turn...
14. House Staffers Mull Strategies To Speed Health Bill PassageCongressDaily: "Congressional Democrats are laying groundwork that would allow the House to pass the Senate's healthcare overhaul bill without a conference, a move that would avoid additional Senate filibusters and...
15. Data Mining By Drug Companies Raises ConcernThe Los Angeles Times examines a practice called data mining in which drug companies track how doctors prescribe medications by obtaining data from pharmacies and health insurers. "That information has...